Navigation Links
Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
Date:8/20/2009

A recent New York Times article, ''Senator Moves to Block Medical Ghostwriting,'' raises a heinous accusation, that Wyeth paid medical ghostwriters to suppress clinical evidence linking the use of synthetic hormone drugs to an increased risk of breast cancer.

Jacksonville, Fla. (Vocus) August 20, 2009 -- A recent New York Times article, ''Senator Moves to Block Medical Ghostwriting,'' raises a heinous accusation, that Wyeth paid medical ghostwriters to suppress clinical evidence linking the use of synthetic hormone drugs to an increased risk of breast cancer.

"I am gratified that the truth may finally be coming to light," said C.W.Randolph, Jr., M.D., "Even after the 2002 National Institutes of Health, Women's Health Initiative Trial (WHI) irrefutably established that synthetic hormones (such as the popularly prescribed Premarin family of products) caused the risk of breast cancer to increase 26 percent, physicians continued to prescribe these drugs putting millions of women's lives in jeopardy. Why? Because they were misled by pharmaceutical-sponsored medical studies skewing the facts."

According to Dr. Randolph, a nationally recognized medical expert in the field of natural, or Bioidentical Hormone Replacement Therapies (BHRT), this type of evidence has existed for decades.

As early as 1941, Edgar Allen, M.D., Chair of Yale Medical School Anatomy Department, published an article in the medical journal Cancer Research on the propensity of estrogen to cause cancer in animals. Since that time, the output of medical research and clinical studies continued to mount until, in 2001, representatives from the National Cancer Institute and the National Institutes of Health (NIH) voted 8-1 to add synthetic estrogen to the nation's list of cancer-causing agents.

Recent revelations that Wyeth directed DesignWrite medical ghostwriters to deliberately deemphasize the links between synthetic hormone replacement therapies and breast cancer in published medical journals are bringing experts in the field of BHRT to answer the question of the purpose for manipulating this data.

''Because there is big money at stake,'' says Genie James, M.M.Sc., Executive Director of the Natural Hormone Institute. ''Prior to the WHI findings being made public in 2002, the Premarin-family of products was a 2.2 billion dollar pipeline.''

According to an article in The New York Times, since 2002, sales for Wyeth's Premarin family of products have plummeted 50 percent, and have continued to decline over the last several years.

Research in the U.S. and around the world supports BHRT as the treatment of choice for menopausal symptoms and conditions of hormone imbalance.

"The sad reality is that when marketing gets ahead of medical science, women's lives are put at risk," says James.

About C.W. Randolph, Jr., M.D.: Randolph is an internationally renowned expert in the field of bio-identical hormone replacement. He is a board-certified obstetrician and gynecologist who practiced as a compounding pharmacist. He is the co-founder of the Natural Hormone Institute, a Diplomat of the American Board of Holistic Medicine, and a member of the International Academy of Compounding Pharmacists. He coauthored ''From Belly Fat to Belly Flat, From Hormone Hell to Hormone Well,'' and ''In the Mood Again'' (Simon & Schuster 2010).

About Genie James, M.M.Sc.: Genie is nationally acknowledged as a change-agent for improved women's health. She is the co-founder and executive director of the Natural Hormone Institute. She coauthored ''From Belly Fat to Belly Flat, From Hormone Hell to Hormone Well,'' and ''In the Mood Again'' (Simon & Schuster 2010).

Media Contact
Nanette Noffsinger
Burke Hollow Media
(615) 776-4230
nanette(at)burkehollowmedia(dot)com

###

Read the full story at http://www.prweb.com/releases/Breast_Cancer/Synthetic_Hormones/prweb2777324.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Recent Completion of Purdue U.S. License and Collaboration Agreement
2. Statement from the American College of Surgeons Regarding Recent Comments from President Obama
3. Noted Vertebroplasty Expert Cites Concerns About Recently Published Study
4. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
5. The Obesity Society Position on Recent Criticism of Surgeon General Nominee Regina Benjamin
6. Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading: Studies Actually Show it is Effective at Reducing Pain
7. ReGen Biologics Clarifies Recent Press about the Menaflex Device
8. Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
9. PracticeMatch Releases Results of Recent State of the Industry Survey of Physician Recruiters
10. Recently Released Data from the National Survey of Childrens Health Reports That Autism Now Affects 1% of Children and is More Common Than Childrens Cancer, Diabetes, and AIDS Combined.
11. American Association for Homecare Sets the Record Straight About Recent Home Medical Equipment Issues in the News
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
(Date:3/27/2017)... ... March 27, 2017 , ... American ... conference coverage on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a ... with the April edition of American Veterinarian™. , “We look forward ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... research products enables researchers to pursue the recent RNA methylation “gold rush” with ... In light of the newfound characteristics of N6-methyladenosine, or m6A , RNA ...
(Date:3/27/2017)... , ... March 27, 2017 , ... According to the ... cancer, including all stages, is more than 95%. Once the cancer spreads to other ... than 30%. To find out how to avoid this latter group, tune in to ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending LLC announced ... litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil No. 1:14-CV-00121-CW/ ... to announce that we have now reached a settlement agreement regarding the ongoing ...
(Date:3/27/2017)... HOUSTON, Texas (PRWEB) , ... March 27, 2017 , ... ... and hard of hearing, is bringing its latest products to the Deaf Seniors of ... attendees will have the opportunity to meet with knowledgeable ASL friendly staff from Harris ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Cryoport, Inc. (NASDAQ: CYRX, ... intends to offer shares of common stock in an ... on file with the Securities and Exchange Commission (the ... conditions, and there can be no assurance as to ... as to the actual size or terms of the ...
(Date:3/27/2017)... 27, 2017  A new survey from ... Medicare,s Competitive Bidding Program (CBP) significantly reduced beneficiary choice ... lack of choice forces beneficiaries to switch to unfamiliar ... consequences. AADE,s survey is the latest ... others pointing out the inherent problems with the CBP. ...
(Date:3/27/2017)... March 27, 2017 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ... 8IS) Invictus MD is pleased to announce it has ... trading on the TSX Venture Exchange.  ... a year of significant achievements for Invictus-MD. Some of ... crops at AB Laboratories Inc. ("AB Labs"), a Licensed ...
Breaking Medicine Technology: